US Physicalrapy Inc (USPH) Financials

$77.87

$-0.84 (-1.07%)

As on 09-Sep-2026 16:07EDT

Market cap

$1,174 Mln

Revenue (TTM)

$779 Mln

P/E Ratio

462.6

P/B Ratio

2.6

Div. Yield

2.3 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	779.10	780.99	671.35	604.80	553.14	495.02
Cost of Revenue	629.73	623.65	547.42	483.29	441.12	377.84
Gross Profit	149.37	157.34	123.92	121.51	112.02	117.18
Operating Expenses	65.14	76.91	60.71	69.45	55.22	46.53
Operating Profit (EBIT)	84.23	80.43	63.21	52.06	56.80	70.65
Other Income	--	--	--	--	--	2.55
Profit before Tax	67.45	77.81	60.21	49.38	55.57	73.20
Provision for Tax	17.58	19.81	14.61	12.16	12.16	15.27
Profit after Tax (Net Income)	-6.03	15.06	26.46	14.67	28.27	27.82
Minority Interest	-57.93	-42.94	-19.14	-20.36	-11.25	-17.09
Consolidated Profit	--	--	--	--	29.26	40.83

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	448.66	476.43	488.93	476.19	315.79	295.61
Minority Interest	-57.93	--	--	--	--	1.58
Non-Current Liabilities	372.31	294.77	292.14	242.82	288.10	213.50
Current Liabilities	109.91	139.04	116.28	102.19	85.49	83.48
Total Liabilities	1,358.78	1,204.01	1,167.47	997.24	858.15	749.43

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	1,109.20	1,064.02	1,029.88	763.86	746.89	654.26
Current Assets	139.68	139.99	137.58	233.38	111.27	95.17
Total Assets	1,358.78	1,204.01	1,167.47	997.24	858.15	749.43
Total Debt*	385.79	425.74	295.23	258.59	295.34	223.08
Net Current Assets	29.77	0.95	21.30	131.19	25.78	11.69

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	75.06	74.94	81.98	58.54	76.41
Cash Flow from Investing Activities	--	-36.71	-149.45	-45.02	-81.27	-124.14
Cash from Financing Activities	--	-44.14	-36.95	84.27	25.76	43.38
Net Cash Inflow / Outflow	--	--	--	--	--	-4.35

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	-0.40	0.99	1.76	0.98	2.17	2.15
Cash EPS ($)	--	2.47	3.00	2.01	3.31	3.05
Adjusted Book Value ($)	--	31.40	32.46	31.77	24.29	22.89
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	4.95	4.97	5.47	4.50	5.92
Free Cash Flow per Share ($)	--	4.02	4.36	4.85	3.87	5.28

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	1.79	3.48	2.18	5.00	6.14
ROE (%)	-13.83	3.12	5.48	3.71	9.25	9.73
ROA (%)	-0.45	1.27	2.44	1.58	3.52	4.14
EBIT Margin (%)	10.04	11.17	10.16	9.70	11.09	14.98
Net Margin (%)	-0.77	1.93	3.94	2.43	5.11	5.59
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	17.12	0.16	0.11	0.09	0.12	0.17
EBIT Growth (%)	-1.51	27.92	16.27	-4.35	-17.25	10.41
Net Profit Growth (%)	-652.20	-43.08	80.32	-48.09	1.61	-8.97
EPS Growth (%)	-118.99	-0.43	0.79	-0.55	0.01	-0.09
Book Value Growth (%)	-9.65	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	462.59	78.68	50.50	95.13	37.27	44.35
Price / Book Value	2.59	2.49	2.73	2.93	3.34	4.17
Dividend Yield (%)	2.33	--	--	--	--	--
EV/EBITDA	15.12	14.36	18.30	20.15	17.27	16.66
Close Price ($)	68.68	78.09	88.71	93.14	81.03	95.55
High Price ($)	93.50	93.50	113.63	124.11	131.50	143.67
Low Price ($)	58.19	62.77	76.18	78.08	73.30	84.43
Market Cap ($ Cr)	1,173.52	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	0.48	0.89	0.60	0.54	0.94	0.75
Short term debt to equity ratio	0.11	0.11	0.10	0.09	0.13	0.11
Current Ratio	1.27	1.01	1.18	2.28	1.30	1.14
Quick Ratio	1.27	--	--	2.31	1.33	1.14
Interest Coverage	7.27	9.23	8.51	6.31	10.62	78.70

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	12.60	11.31	12.76	11.53	12.53	12.61
Asset Turnover	0.59	0.66	0.62	0.65	0.69	0.74
Receivable days	--	40.69	42.27	41.98	43.49	41.82
Inventory Days	--	--	-1.78	-2.09	-1.18	0.00
Payable days	--	3.51	3.28	3.93	5.37	3.77
Cash Conversion Cycle	--	--	37.21	35.96	36.93	38.05

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)